FOXP3 and cancer: Among tumor-infiltrating lymphocytes (TILs), the number of CD8+ is significantly lower in those cases carrying IPF, whereas the CD8+/Foxp3+ T cell ratio was higher than that in the non-IPF cancer population [110].